Naitik Jain

436 total citations
29 papers, 328 citations indexed

About

Naitik Jain is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Naitik Jain has authored 29 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomaterials, 11 papers in Biomedical Engineering and 9 papers in Molecular Biology. Recurrent topics in Naitik Jain's work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (8 papers) and RNA Interference and Gene Delivery (7 papers). Naitik Jain is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (8 papers) and RNA Interference and Gene Delivery (7 papers). Naitik Jain collaborates with scholars based in India and United States. Naitik Jain's co-authors include Paras Famta, Saurabh Srivastava, Shashi Bala Singh, Saurabh Shah, Dadi A. Srinivasarao, Ganesh Vambhurkar, Dharmendra Kumar Khatri, Rajeev Singh Raghuvanshi, Giriraj Pandey and Anamika Sharma and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Naitik Jain

27 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naitik Jain India 12 143 114 104 42 34 29 328
Yufan Xiang China 9 129 0.9× 95 0.8× 115 1.1× 34 0.8× 40 1.2× 16 379
Samuel Brook United States 3 111 0.8× 74 0.6× 102 1.0× 41 1.0× 34 1.0× 4 265
Lifang Jin China 10 144 1.0× 49 0.4× 71 0.7× 47 1.1× 25 0.7× 22 316
Zhongyue Yuan China 10 171 1.2× 186 1.6× 138 1.3× 47 1.1× 26 0.8× 15 430
Wencan Wu China 10 192 1.3× 41 0.4× 83 0.8× 34 0.8× 35 1.0× 37 385
Reza Abbasi Iran 10 139 1.0× 91 0.8× 86 0.8× 30 0.7× 21 0.6× 15 367
Mahsa Akbari Oryani Iran 12 215 1.5× 77 0.7× 129 1.2× 101 2.4× 49 1.4× 28 518
Junjie Liu China 10 181 1.3× 150 1.3× 132 1.3× 130 3.1× 23 0.7× 14 370
Yuesong Wu China 8 121 0.8× 103 0.9× 117 1.1× 33 0.8× 74 2.2× 20 320
Azam Bozorgi Iran 9 121 0.8× 68 0.6× 82 0.8× 83 2.0× 18 0.5× 19 314

Countries citing papers authored by Naitik Jain

Since Specialization
Citations

This map shows the geographic impact of Naitik Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naitik Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naitik Jain more than expected).

Fields of papers citing papers by Naitik Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naitik Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naitik Jain. The network helps show where Naitik Jain may publish in the future.

Co-authorship network of co-authors of Naitik Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Naitik Jain. A scholar is included among the top collaborators of Naitik Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naitik Jain. Naitik Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Naitik, et al.. (2025). Peptide dendrimer and hyaluronic acid modified nanovesicles for ocular delivery of timolol maleate and siRNA. Scientific Reports. 15(1). 26074–26074. 1 indexed citations
2.
Sarkar, Tukki, Arpan Bera, Naitik Jain, et al.. (2025). Photostable Mn(II) Complex of Curcumin for Effective Photodynamic Therapy and Precise Three-Dimensional In Vivo Tumor Imaging. ACS Applied Materials & Interfaces. 17(9). 13660–13675. 4 indexed citations
3.
Jain, Naitik, et al.. (2025). Unlocking the future: Precision oligonucleotide therapy for targeted treatment of neurodegenerative disorders. International Journal of Biological Macromolecules. 310(Pt 4). 143515–143515. 1 indexed citations
4.
Shah, Saurabh, Paras Famta, Dadi A. Srinivasarao, et al.. (2024). Nanomedicine-RNAi interface: Architypes in prostate cancer therapeutics. Journal of Drug Delivery Science and Technology. 92. 105349–105349. 4 indexed citations
5.
Srinivasarao, Dadi A., Saurabh Shah, Paras Famta, et al.. (2024). Unravelling the role of tumor microenvironment responsive nanobiomaterials in spatiotemporal controlled drug delivery for lung cancer therapy. Drug Delivery and Translational Research. 15(2). 407–435. 11 indexed citations
6.
Famta, Paras, Dadi A. Srinivasarao, Ganesh Vambhurkar, et al.. (2023). Neutrophil membrane-based nanotherapeutics: Propitious paradigm shift in the management of cancer. Life Sciences. 331. 122021–122021. 17 indexed citations
7.
Shah, Saurabh, Paras Famta, Dadi A. Srinivasarao, et al.. (2023). Unravelling the potential of microbots in cancer therapy. Applied Materials Today. 34. 101887–101887. 2 indexed citations
8.
Jain, Naitik, Paras Famta, Saurabh Shah, et al.. (2023). Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma. Journal of Drug Delivery Science and Technology. 84. 104453–104453. 23 indexed citations
9.
Famta, Paras, Saurabh Shah, Naitik Jain, et al.. (2023). Nanocarrier-based drug delivery via cell-hitchhiking: Emphasizing pharmacokinetic perspective towards taming the “big-old” tumors. Journal of Drug Delivery Science and Technology. 89. 105050–105050. 11 indexed citations
10.
Pandey, Giriraj, Saurabh Shah, Paras Famta, et al.. (2023). ‘Nano-in-nano’ – Breaching the barriers of the tumor microenvironment using nanoparticle-incorporated nanofibers. Journal of Drug Delivery Science and Technology. 91. 105249–105249. 15 indexed citations
11.
Jain, Naitik, Saurabh Shah, Paras Famta, et al.. (2023). Aptamer guided nanomedicine strategies in prostate cancer: Targeting and diagnosis. Journal of Drug Delivery Science and Technology. 85. 104593–104593. 6 indexed citations
12.
Shah, Saurabh, Paras Famta, Ganesh Vambhurkar, et al.. (2023). Sulfo-butyl ether β-cyclodextrin inclusion complexes of bosutinib: in silico, in vitro and in vivo evaluation in attenuating the fast-fed variability. Drug Delivery and Translational Research. 14(5). 1218–1231. 3 indexed citations
13.
Shah, Saurabh, Paras Famta, Ganesh Vambhurkar, et al.. (2023). Quality by design accredited self-nanoemulsifying delivery of ibrutinib for extenuating the fast-fed variability, ameliorating the anticancer activity and oral bioavailability in prostate cancer. Journal of Drug Delivery Science and Technology. 89. 105052–105052. 8 indexed citations
14.
Vambhurkar, Ganesh, Paras Famta, Saurabh Shah, et al.. (2023). Quality by Design Galvanized development of resveratrol loaded PLGA nanoparticles: In vitro and Ex vivo evaluation for the non-invasive treatment of metastatic melanoma. Journal of Drug Delivery Science and Technology. 91. 105252–105252. 11 indexed citations
15.
Shah, Saurabh, Paras Famta, Naitik Jain, et al.. (2023). Multifaceted applications of ulvan polysaccharides: Insights on biopharmaceutical avenues. International Journal of Biological Macromolecules. 234. 123669–123669. 26 indexed citations
16.
Famta, Paras, Saurabh Shah, Ganesh Vambhurkar, et al.. (2023). Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia. European Journal of Pharmaceutics and Biopharmaceutics. 190. 94–106. 19 indexed citations
17.
Famta, Paras, Saurabh Shah, Ganesh Vambhurkar, et al.. (2023). Quality by design (QbD) commended exploration of bosutinib loaded lipid nanocarriers for food effect attenuation and bioavailability enhancement in breast cancer. Journal of Drug Delivery Science and Technology. 90. 105180–105180. 5 indexed citations
18.
Tryphena, Kamatham Pushpa, Gurpreet Singh, Naitik Jain, et al.. (2023). Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics. Mechanisms of Ageing and Development. 211. 111800–111800. 26 indexed citations
19.
Famta, Paras, Saurabh Shah, Naitik Jain, et al.. (2022). Albumin-hitchhiking: Fostering the pharmacokinetics and anticancer therapeutics. Journal of Controlled Release. 353. 166–185. 42 indexed citations
20.
Famta, Paras, Saurabh Shah, Naitik Jain, et al.. (2022). Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer. Life Sciences. 310. 121125–121125. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yufan Xiang Breakdown of academic impact, for papers by Samuel Brook Breakdown of academic impact, for papers by Lifang Jin Breakdown of academic impact, for papers by Zhongyue Yuan Breakdown of academic impact, for papers by Wencan Wu Breakdown of academic impact, for papers by Reza Abbasi Breakdown of academic impact, for papers by Mahsa Akbari Oryani Breakdown of academic impact, for papers by Junjie Liu Breakdown of academic impact, for papers by Yuesong Wu Breakdown of academic impact, for papers by Azam Bozorgi
Rankless by CCL
2026